You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Proportion of women with viral load ≥400 copies/mL, immunologic failure and self-report on drug adherence in Mitra Plus women on ART for life

From: Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania

Time point Number with viral load ≥ 400 copies/ml/number tested (%) Number with immunologic failure/number tested (%) Drug adherence; Number adhering/number tested (%)
Enrolment 71/73 (97%) -  
Month 3 11/67 (16%) - 64/68 (95%)
Month 6 15/69 (22%) 8/69 (12%) 56/66 (85%)
Month 12 36/59 (61%) 15/60 (25%) 39/53 (74%)
Month 24 48/56 (86%) 24/58 (41%) 30/46 (65%)